12 August 2021 - Deborah Wilkes
Premium
Bayer Consumer Health said its North American business had performed “very well” in the second quarter of 2021, thanks to a strong allergy season, continued high demand for Nutritionals and the launch of AleveX.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.